全文获取类型
收费全文 | 159045篇 |
免费 | 31648篇 |
国内免费 | 2452篇 |
专业分类
耳鼻咽喉 | 5312篇 |
儿科学 | 5635篇 |
妇产科学 | 2586篇 |
基础医学 | 4289篇 |
口腔科学 | 1701篇 |
临床医学 | 27270篇 |
内科学 | 49104篇 |
皮肤病学 | 7616篇 |
神经病学 | 15759篇 |
特种医学 | 6746篇 |
外科学 | 41878篇 |
综合类 | 279篇 |
现状与发展 | 72篇 |
预防医学 | 7511篇 |
眼科学 | 3536篇 |
药学 | 1490篇 |
中国医学 | 55篇 |
肿瘤学 | 12306篇 |
出版年
2024年 | 701篇 |
2023年 | 4849篇 |
2022年 | 1344篇 |
2021年 | 3294篇 |
2020年 | 6139篇 |
2019年 | 2351篇 |
2018年 | 7622篇 |
2017年 | 7518篇 |
2016年 | 8594篇 |
2015年 | 8627篇 |
2014年 | 15741篇 |
2013年 | 15931篇 |
2012年 | 5985篇 |
2011年 | 6026篇 |
2010年 | 10672篇 |
2009年 | 14522篇 |
2008年 | 6276篇 |
2007年 | 4531篇 |
2006年 | 7008篇 |
2005年 | 4234篇 |
2004年 | 3482篇 |
2003年 | 2467篇 |
2002年 | 2479篇 |
2001年 | 3948篇 |
2000年 | 3143篇 |
1999年 | 3359篇 |
1998年 | 3733篇 |
1997年 | 3533篇 |
1996年 | 3425篇 |
1995年 | 3265篇 |
1994年 | 1972篇 |
1993年 | 1602篇 |
1992年 | 1431篇 |
1991年 | 1467篇 |
1990年 | 1099篇 |
1989年 | 1230篇 |
1988年 | 1066篇 |
1987年 | 905篇 |
1986年 | 936篇 |
1985年 | 742篇 |
1984年 | 575篇 |
1983年 | 549篇 |
1982年 | 537篇 |
1981年 | 416篇 |
1980年 | 371篇 |
1979年 | 334篇 |
1978年 | 344篇 |
1977年 | 416篇 |
1975年 | 289篇 |
1972年 | 313篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
51.
52.
53.
54.
55.
Vasileios Mourmouras Gabriele Cevenini Elena Cosci Maria C. Epistolato Maurizio Biagioli Letizia Barbagli Pietro Luzi Susanna Mannucci and Clelia Miracco 《Journal of cutaneous pathology》2009,36(6):637-646
Background: Nucleolin is a major nucleolar argyrophilic protein involved in carcinogenesis. There are only few studies on its tissue expression in human cancer and none in melanoma. We aimed at exploring this protein and its prognostic impact in cutaneous melanocytic lesions.
Methods: We studied 193 cases including benign, dysplastic and malignant melanocytic lesions. Nuclear positivity was evaluated by immunohistochemistry and quantified by automated image analysis.
Results: Most dysplastic and malignant lesions showed high percentages of cells with abnormal patterns of nuclear positivity (Abn+N) consisting in multiple, irregular, positive dots (ID+) and a coarse, irregularly positive nucleoplasm (CNpl+) or both (ID+CNpl+). The patterns CNpl+ and/or ID+CNpl+ were never observed in benign lesions, in which ID+ were also virtually absent. Abn+N% was significantly lower in dysplastic nevi than in primary melanomas and metastases and in primary melanomas than in metastases (p < 0.05). Furthermore, Abn+N was the second powerful prognostic discriminator, after melanoma thickness, and a significantly lower survival was observed in vertical growth phase melanoma patients showing Abn+N in more than 50% of melanoma cells.
Conclusion: An altered nuclear nucleolin expression seems to accompany melanoma progression. Further investigation on nucleolin functionality and subcellular trafficking could add information on its altered role in melanoma. 相似文献
Methods: We studied 193 cases including benign, dysplastic and malignant melanocytic lesions. Nuclear positivity was evaluated by immunohistochemistry and quantified by automated image analysis.
Results: Most dysplastic and malignant lesions showed high percentages of cells with abnormal patterns of nuclear positivity (Abn+N) consisting in multiple, irregular, positive dots (ID+) and a coarse, irregularly positive nucleoplasm (CNpl+) or both (ID+CNpl+). The patterns CNpl+ and/or ID+CNpl+ were never observed in benign lesions, in which ID+ were also virtually absent. Abn+N% was significantly lower in dysplastic nevi than in primary melanomas and metastases and in primary melanomas than in metastases (p < 0.05). Furthermore, Abn+N was the second powerful prognostic discriminator, after melanoma thickness, and a significantly lower survival was observed in vertical growth phase melanoma patients showing Abn+N in more than 50% of melanoma cells.
Conclusion: An altered nuclear nucleolin expression seems to accompany melanoma progression. Further investigation on nucleolin functionality and subcellular trafficking could add information on its altered role in melanoma. 相似文献
56.
Milos Jesenak MD PhD Peter Banovcin MD PhD Zuzana Rennerova MD PhD Lubica Jakusova MD PhD Zuzana Havlicekova MD PhD Vladimir Pohanka MD PhD MPH FCCP Maria Pia Villa MD PhD Roberto Ronchetti MD PhD 《International journal of dermatology》2009,48(9):941-946
Background The atopy patch test (APT) is no longer an experimental method; it is increasingly being used as a standard diagnostic tool for the characterization of patients with aeroallergen- and food-triggered disorders. Some technical aspects of this test still remain to be answered. We aimed to study the reproducibility of this test over time in the general child population.
Methods In a general population of 118 children, we investigated the reproducibility of duplicate APTs with four food allergens in their native form, which were repeated at set intervals from the first test: 7 days (group 1), 14 days (group 2), and 21 days (group 3).
Results We observed very poor reproducibility on both sides of the back in all three studied subgroups. The reproducibility rates and Cohen's κ values did not improve when we did not consider the side of the back. There were no differences in the prevalence of atopy between the subjects with reproducible and nonreproducible APT results. All three groups studied showed no difference in the prevalence rates of atopy. There was no relationship between APT and skin prick test positivity for the same allergen. Questionnaire-derived data about previous food-related reactions did not help in the evaluation of the doubtful nonreproducible APT results with food allergens.
Conclusions Our results show that the reproducibility of food APTs is poor and unsatisfactory over time, and there is an urgent need for the development of optimal, stable, and good-quality APT testing substances. 相似文献
Methods In a general population of 118 children, we investigated the reproducibility of duplicate APTs with four food allergens in their native form, which were repeated at set intervals from the first test: 7 days (group 1), 14 days (group 2), and 21 days (group 3).
Results We observed very poor reproducibility on both sides of the back in all three studied subgroups. The reproducibility rates and Cohen's κ values did not improve when we did not consider the side of the back. There were no differences in the prevalence of atopy between the subjects with reproducible and nonreproducible APT results. All three groups studied showed no difference in the prevalence rates of atopy. There was no relationship between APT and skin prick test positivity for the same allergen. Questionnaire-derived data about previous food-related reactions did not help in the evaluation of the doubtful nonreproducible APT results with food allergens.
Conclusions Our results show that the reproducibility of food APTs is poor and unsatisfactory over time, and there is an urgent need for the development of optimal, stable, and good-quality APT testing substances. 相似文献
57.
Ludger Grote MD PhD Lena Leissner MD Jan Hedner MD PhD Jan Ulfberg MD PhD 《Movement disorders》2009,24(10):1445-1452
Iron deficiency may exacerbate symptoms in the Restless Legs Syndrome (RLS). We investigated the effect of intravenous iron sucrose or placebo on symptoms in patients with RLS and mild to moderate iron deficit. Sixty patients with primary RLS (seven males, age 46 (9) years, S‐ferritin ≤45 μg/L) recruited from a cohort of 231 patients were randomly assigned in a 12‐months double‐blind, multi‐centre study of iron sucrose 1000 mg (n = 29) or saline (n = 31). The primary efficacy variable was the RLS severity scale (IRLS) score at week 11. Median IRLS score decreased from 24 to 7 (week 11) after iron sucrose and from 26 to 17 after placebo (P = 0.123, N.S. for between treatment comparison). The corresponding scores at week 7 were 12 and 20 in the two groups (P = 0.017). Drop out rate because of lack of efficacy at 12 months was 19/31 after placebo and 5/29 patients after iron sucrose (Kaplan–Meier estimate, log rank test P = 0.0006) suggesting an iron induced superior long term RLS symptom control. Iron sucrose was well tolerated. This study showed a lack of superiority of iron sucrose at 11 weeks but found evidence that iron sucrose reduced RLS symptoms both in the acute phase (7 weeks) and during long‐term follow up in patients with variable degree of iron deficiency. Further studies on target patient groups, dosing and dosing intervals are warranted before iron sucrose could be considered for treatment of iron deficient patients with RLS. © 2009 Movement Disorder Society 相似文献
58.
59.
60.